share_log

华东医药:浙江天册律师事务所关于华东医药股份有限公司2022限制性股票激励计划预留授予限制性股票第一个解除限售期解除限售条件成就之法律意见书

Huadong Pharmaceutical: Legal Opinion of Zhejiang Tianze Law Firm on the 2022 Restricted Stock Incentive Plan of Huadong Pharmaceutical Co., Ltd. reserves and grants restricted stocks the first time to lift sales restrictions during the sales restriction period and the achievement of lifting the sales restrictions

SZSI ·  Oct 10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more